Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1419-20. doi: 10.1073/pnas.1522052113. Epub 2016 Feb 25.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anilides / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Resistance, Neoplasm / physiology*
  • Humans
  • Models, Molecular*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Proto-Oncogene Proteins / antagonists & inhibitors*
  • Pyridines / pharmacology*

Substances

  • Anilides
  • Antineoplastic Agents
  • Proto-Oncogene Proteins
  • Pyridines
  • Protein-Tyrosine Kinases